You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.

03 November 2017

Young women in South Africa better off with daily PrEP

Young, sexually active women at high risk of HIV in South Africa more likely to take PrEP daily over other time or events-based methods new study finds.

0
02 November 2017

Declines in condom use while on PrEP does not increase HIV risk in sex workers

PrEP for sex workers in South Africa can be a success for HIV prevention, as long as high levels of adherence are maintained.

0
26 September 2017

New research casts doubt on age gap theory of HIV transmission

Research from South Africa suggests a women’s HIV risk may be driven more by their male partner’s age rather than the age gap between them.

0
06 June 2017

Grindr survey reveals many gay men using PrEP without doctor support

There is a high appetite for increased access to pre-exposure prophylaxis (PrEP) among gay app users in Switzerland, according to research looking into the need for a national PrEP programme.

0
09 May 2017

Kenya begins mass roll-out of HIV self-testing and PrEP

Kenya embraces new HIV testing technologies to scale-up HIV prevention efforts in the country.

 

0
26 April 2017

Doctors in the USA see few cases of risk compensation among PrEP users

Most healthcare providers cite worries over risk compensation after providing PrEP, but experiences among doctors who do prescribe PrEP are positive.

0
10 April 2017

Women prefer sex with circumcised men and play key role influencing men's VMMC decision

Women’s views on voluntary male medical circumcision form an important part of the delivery and mass roll-out of this HIV prevention strategy.

0
14 November 2016

Norway provides PrEP for free to all those at risk of HIV

The game-changing drug, Truvada – the only drug approved for PrEP – will be offered to groups considered at risk of HIV.

0
25 October 2016

Understanding the barriers to circumcision in southern and eastern Africa

Despite a willingness of men to undergo voluntary medical male circumcision (VMMC) for HIV prevention benefits in sub-Saharan Africa, uptake is low with just 56% of the 20.8 million circumcisions by 2016 target met.

0
14 September 2016

Europe grants marketing approval of Truvada for use as PrEP

The European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region.

0